Kaoyuan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kaoyuan Zhang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Bo Yu
Department of Dermatology Peking University Shenzhen Hospital Shenzhen Guangdong China
3 shared publications - Chao Chen
Department of Dermatology Peking University Shenzhen Hospital Shenzhen Guangdong China
2 shared publications - Chenchen Wu
Department of Dermatology Peking University Shenzhen Hospital Shenzhen China
2 shared publications - Yan Liao
Department of Dermatology Peking University Shenzhen Hospital Shenzhen Guangdong China
2 shared publications - Chener Yang
Department of Dermatology Peking University Shenzhen Hospital, Institute of Dermatology, Shenzhen Peking University—The Hong Kong University of Science and Technology Medical Center Shenzhen China
1 shared publication - Cong Huang
Department of Dermatology Peking University Shenzhen Hospital Shenzhen China
1 shared publication
Latest Publications
- 17 December 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (S2) , 42-51
Clinical Characteristics and Serum CGRP Level Differences Between Neurogenic Rosacea and Non‐Neurogenic Rosacea
Background: There are limited reports on neurogenic rosacea (NR), and further clarifications are needed regarding its clinical manifestations, serological indicators, and treatment response. Objective: Our aim was to explore the clinical features and potential serological biomarkers of NR. Methods: We collected and analyzed the clinical characteristics, triggers, psychological burden, and treatment of 251 rosacea patients. According to the 2017 International Diagnostic Criteria for Rosacea, key clinical symptoms, and response to conventional treatment, the cohort was divided into 32 NR patients and 219 non‐neurogenic rosacea (NNR) patients. Serum neuropeptide levels were detected in 20 NR patients and 20 matched NNR controls. Clinical characteristics, serum neuropeptide differences, and correlations were assessed. Results: NR patients exhibited more severe and more frequent flushing. Besides, neuroinflammatory‐related symptoms, such as burning, occur more frequently in NR patients. The serum calcitonin gene‐related peptide (CGRP) levels were significantly elevated in NR patients and correlated with clinical severity, flushing severity of rosacea, and treatment outcome. Conclusion: NR patients experienced more severe flushing and other neuroinflammatory‐related symptoms. The increased serum CGRP level was positively correlated with the severity of NR, suggesting its potential as an adjunct biomarker to screen for NR in rosacea patients and guide treatment.
- 17 December 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (S2) , 42-51
Clinical Characteristics and Serum CGRP Level Differences Between Neurogenic Rosacea and Non‐Neurogenic Rosacea
Background: There are limited reports on neurogenic rosacea (NR), and further clarifications are needed regarding its clinical manifestations, serological indicators, and treatment response. Objective: Our aim was to explore the clinical features and potential serological biomarkers of NR. Methods: We collected and analyzed the clinical characteristics, triggers, psychological burden, and treatment of 251 rosacea patients. According to the 2017 International Diagnostic Criteria for Rosacea, key clinical symptoms, and response to conventional treatment, the cohort was divided into 32 NR patients and 219 non‐neurogenic rosacea (NNR) patients. Serum neuropeptide levels were detected in 20 NR patients and 20 matched NNR controls. Clinical characteristics, serum neuropeptide differences, and correlations were assessed. Results: NR patients exhibited more severe and more frequent flushing. Besides, neuroinflammatory‐related symptoms, such as burning, occur more frequently in NR patients. The serum calcitonin gene‐related peptide (CGRP) levels were significantly elevated in NR patients and correlated with clinical severity, flushing severity of rosacea, and treatment outcome. Conclusion: NR patients experienced more severe flushing and other neuroinflammatory‐related symptoms. The increased serum CGRP level was positively correlated with the severity of NR, suggesting its potential as an adjunct biomarker to screen for NR in rosacea patients and guide treatment.
- Open Access
- 25 September 2025
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 13 (9) , e70263
Serum SERPINB3/4 in Moderate‐to‐Severe Prurigo Nodularis: A Potential Biomarker for Disease Severity and Eosinophil‐Related Parameters
Background: The available evidence increasingly indicates that SERPINB3/4 plays a pivotal role in the progression of inflammatory diseases and may serve as a valuable biomarker for atopic dermatitis and psoriasis. However, the expression of SERPINB3/4 in the serum of patients with moderate‐to‐severe prurigo nodularis (PN) remains poorly understood. Objective: To find a promising biomarker for monitoring the severity and activity of moderate‐to‐severe PN patients. Methods: A total of 41 patients with moderate‐to‐severe PN and 20 healthy subjects were included in the study. Enzymelinked immunosorbent assay (ELISA) was performed to determine serum SERPINB3/4 expression. Cutaneous SERPINB3/4 expression was evaluated by immunohistochemistry (IHC). Serum SERPINB3/4 levels were correlated with PN disease severity and activity scores, hematological parameters, and systemic inflammatory markers. Results: SERPINB3/4 expression was found to be significantly increased in the serum and lesions of PN in comparison to healthy subjects. In patients with PN, the expression of serum SERPINB3/4 was significantly elevated in subjects with higher investigator global assessment (IGA) scores, while exhibiting a notable decline in patients with higher pruritus numeric rating scale (P‐NRS) scores. Positive correlations were observed between serum SERPINB3/4 levels and peripheral eosinophil count, eosinophil ratio, and eosinophil‐to‐lymphocyte ratio (ELR) in patients with PN. Conclusion: SERPINB3/4 expression was increased in PN sera and lesions. Serum SERPINB3/4 expression was positively correlated with PN severity and peripheral eosinophil‐related parameters, suggesting its potential as a promising biomarker for PN.
- 25 September 2025
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 13 (9) , e70263
Open AccessSerum SERPINB3/4 in Moderate‐to‐Severe Prurigo Nodularis: A Potential Biomarker for Disease Severity and Eosinophil‐Related Parameters
Background: The available evidence increasingly indicates that SERPINB3/4 plays a pivotal role in the progression of inflammatory diseases and may serve as a valuable biomarker for atopic dermatitis and psoriasis. However, the expression of SERPINB3/4 in the serum of patients with moderate‐to‐severe prurigo nodularis (PN) remains poorly understood. Objective: To find a promising biomarker for monitoring the severity and activity of moderate‐to‐severe PN patients. Methods: A total of 41 patients with moderate‐to‐severe PN and 20 healthy subjects were included in the study. Enzymelinked immunosorbent assay (ELISA) was performed to determine serum SERPINB3/4 expression. Cutaneous SERPINB3/4 expression was evaluated by immunohistochemistry (IHC). Serum SERPINB3/4 levels were correlated with PN disease severity and activity scores, hematological parameters, and systemic inflammatory markers. Results: SERPINB3/4 expression was found to be significantly increased in the serum and lesions of PN in comparison to healthy subjects. In patients with PN, the expression of serum SERPINB3/4 was significantly elevated in subjects with higher investigator global assessment (IGA) scores, while exhibiting a notable decline in patients with higher pruritus numeric rating scale (P‐NRS) scores. Positive correlations were observed between serum SERPINB3/4 levels and peripheral eosinophil count, eosinophil ratio, and eosinophil‐to‐lymphocyte ratio (ELR) in patients with PN. Conclusion: SERPINB3/4 expression was increased in PN sera and lesions. Serum SERPINB3/4 expression was positively correlated with PN severity and peripheral eosinophil‐related parameters, suggesting its potential as a promising biomarker for PN.
- 3 September 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (4) , 864-875.e5
Paxbp1 Is Indispensable for the Maintenance of Epidermal Homeostasis
- 3 September 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (4) , 864-875.e5
Paxbp1 Is Indispensable for the Maintenance of Epidermal Homeostasis